In keeping with the spirit of openness, ASCP presents disclosures by our Board members, the members of the Meetings/CME Committee, and our administrative staff. For most, disclosures are for the last year. [Updated October, 2009]
ASCP Board of Directors
Richard Balon, M.D. (July 8, 2009)
none
Anita H. Clayton, M.D. (July 20, 2009)
Advisory Board Fee/Consultant Fee: Boehringer-Ingelheim, Bristol-Myers Squibb,
Eli Lilly, New England Research Institutes, Pfizer, PGxHealth; Sanofi-Aventis; Takeda; TransTech Pharma, Wyeth
Grant/Research Support: BioSante Pharmaceuticals, Boehringer-Ingelheim; Bristol-Myers Squibb,Eli Lilly, Pfizer, Sanofi-Aventis
Royalties/Patents/Other Income:
Ballantine Books/Random House; Guilford Publications; Healthcare Technology Systems, Inc.; Changes in Sexual Functioning Questionnaire
Compositions and Methods for Diagnosing and Monitoring the Development of Tardive Dyskinesia, Inventors: Atmaram Yarlagadda and Anita Clayton, PatentFoundationUniversity of Virginia
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria:
Eli Lilly
Stock Shareholder:
none
Christoph
U.
Correll, M.D. (July 31, 2009)
Advisory Board Fee/Consultant Fee:
AstraZeneca, BMS, Cephalon, Eli Lilly, Ortho
McNeill-Janssen, Medicure, Otsuka, Supernus, Vanda
Grant/Research Support: none
Salaried Positions: none
Royalties/Patents/Other Income: none
Speaker’s Bureau/CME/Honoraria:
AstraZeneca, BMS, Otsuka, Pfizer
Stock Shareholder: none
Maurizio Fava, M.D. (April 21, 2009) (lifetime disclosures)
Advisory Board Fee/Consultant Fee:
Abbott Laboratories, Amarin,Aspect Medical
Systems, AstraZeneca, Auspex, Bayer AG, Best Practice Project Management, Inc, Biovail, BrainCells, Bristol-Myers Squibb, Cephalon, Clinical Trials Solutions, CNS Response, Compellis, Cypress, Dov, Eli Lilly, EPIX, Fabre-Kramer, Forest, GlaxoSmithKline, Grunenthal, GmBH, Janssen, Jazz, Johnson and Johnson, Knoll, Labopharm , Lorex, Lundbeck , MedAvante, Merck, Methylation Sciences, Neuronetics, Novartis, Nutrition 21, Organon, PamLab, Pfize, PharmaStar , Pharmavite , Precision Human Biolaboratory, Roche, Sanofi-Aventis, Sepracor, Schering-Plough, Solvay, Somaxon, Somerset, Synthelabo, Takeda, Tetragenex, Transcept, Vanda, Wyeth-Ayerst Laboratories
Grant/Research Support:
Abbott, Alkermes, Aspect Medical Systems, AstraZeneca,
Bio Research, BrainCells, Bristol-Myers Squibb, Cephalon, Clinical Trial Solutions, Eli Lilly, Forest, Ganeden, GlaxoSmithKline, Johnson and Johnson, Lichtwerd, GmbH, Lorex, Novartis, Organon, PamLab,, Pfizer, Pharmavite, Roche, Sanofi-Aventis, Shire, Solvay Pharmaceuticals, Inc., Synthelabo, Wyeth-Ayerst Laboratories
Royalies/Patents/Other Income
:
See Speaker’s Bureau/Honoraria
Salaried Positions:
none
Speaker’s Bureau/CME/Honoraria:
Advanced Meeting Partners,
AstraZeneca,
Belvoir, Boehringer-Ingelheim, Bristol-Myers Squibb, Cephalon, Lilly,
GlaxoSmithKline, Imedex , Novartis, Organon, Pfizer, PharmaStar, MGH
Psychiatry Academy/Primedia, MGH Psychiatry Academy/Reed-Elsevier,
UBC,
Wyeth-Ayerst Laboratories
Stock Shareholder:
Compellis
Marlene Freeman, M.D. (July 31, 2009)
Advisory Board Fee/Consultant Fee:
PamLab
Grant/Research Support:
GlaxoSmithKline, Eli Lilly, Forest
Royalties/Patents/Other Income:
none
Salaried Positions
: none
Speaker's Bureau/CME/Honoraria:
PamLab
Stock Shareholder:
none
Alan J. Gelenberg, M.D. (March 4, 2009)
Advisory Board Fee/Consultant Fee:
AstraZeneca, Best Practice, Cyberonics,
Eli Lilly, GlaxoSmithKline, Forest, Jazz, Novartis, Pfizer, Wyeth, ZARS Pharma
Grant/Research Support:
Eli Lilly
Royalties/Patents/Other Income: none
Salaried Positions:
Healthcare Technology Systems, Inc (Principal)
Speaker’s Bureau/CME/Honorarium: Wyeth
Stock Shareholder: none
Ira D. Glick, MD (September 23, 2009) (last 3 years)
Advisory Board Fee/Consultant Fee:
BMS, Janssen, Lilly, Organon, Pfizer, Shire,
Solvay, Vanda, Lundbeck
Grant/Research Support:
Astra-Zeneca, BMS/Otsuka, GlaxoSmithKline, Solvay, Shire,
Eli Lilly
Royalties/Patents/Other Income: none
Salaried Positions:
none
Speaker’s Bureau/CME/Honorarium: Astra-Zeneca, Janssen, Pfizer
Stock Shareholder: Johnson & Johnson
James W. Jefferson, M.D. (July 8, 2009)
Advisory Board Fee/Consultant Fee:
GlaxoSmithKline
Grants/Research Support: Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Novartis,
Pfizer, Wyeth
Royalties/Patents/Other Income: Various, from time to time, from the pharmaceutical companies listed above
Salaried Positions: Healthcare Technology Systems, Inc. (Principal)
Speaker’s Bureau/Honoraria: Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly,
Wyeth
Stock Shareholder: Bristol-Myers Squibb, GlaxoSmithKline, SciClone
Arifulla Kahn
, MD
(career)
Advisory Board Fee/Consultant Fee: none
Grant/Research Support: clinical trials sponsored by over 55 pharmaceutical
companies and 30 CROs
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria: none
Stock Shareholder: none
John M. Kane, M.D. (September 22, 2009)
Advisory Board Fee/Consultant Fee: Astra-Zeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly and Co., Janssen, Johnson & Johnson PRD, Lundbeck, Otsuka, Pfizer, Inc., PGxHealth, Proteus Vanda Pharmaceutical, Wyeth Pharmaceutical
Grant/Research Support:
none
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria:
Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Janssen
Stock Shareholder:
MedAvante
Craig Nelson, M.D. (August 4, 2009)
Advisory Board Fee/Consultant Fee:
Bristol-Myers Squibb, Corcept, Covidien, Eli Lilly, Medtronic, Merck, Orexigen, Otsuka, Sanofi-Aventis, Shire, Sierra Neuropharmaceuticals
Grant/Research Support:
none
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria:
none
Stock Shareholder: none
John W. Newcomer, M.D. (April 6, 2009)
Advisory Board Fee/Consultant Fee:
AstraZeneca, Bristol-Myers Squibb,
Dainippon-Sumitomo, GlaxoSmithKline, H. Lundbeck, Janssen, Organon,
Otsuka, Pfizer, Schering-Plough, Solvay, Tikvah, Vanda, Vivus, Wyeth
Grant/Research Support:
Bristol-Myers Squibb, Janssen Pharmaceutica, Pfizer,
Wyeth
Royalties/Patents/Other Income:
Compact Clinicals/Jones and Bartlett Publishing
(for Metabolic Screening forms)
Salaried Positions: none
Speaker’s Bureau/Honoraria: none
Stock Shareholder: none
Harold A Pincus, MD (September 29, 2009)
Advisory Board Fee/Consultant Fee: Value Options
Grant/Research Support: none
Royalties/Patents/Other Income:
American Psychiatric Press, Inc.; Current Opinion in
Psychiatry/Lippincott, William and Wilkins
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria: none
Stock Shareholder: none
William Z. Potter, MD, PhD (July 17, 2009)
Advisory Board Fee/Consultant Fee: none
Grant/Research Support: none
Royalties/Patents/Other Income: none
Salaried Positions:
Merck (Employee)
Speaker’s Bureau/CME/Honoraria: none
Stock Shareholder: none
Mark Hyman Rapaport, M.D. (July 9, 2009)
Advisory Board Fee/Consultant Fee: Pfizer
Grant/Research Support: Astellas, Brain Cells, Dainippon-Sumitomo, Pfizer,
Quintiles, Takeda, Wyeth
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria: none
Stock Shareholder: none
Michael Thase, MD (September 8, 2009)
Advisory Board Fee/Consultant Fee: Astra-Zeneca, Bristol-Myers Squibb Company, Eli Lilly, Forest Pharmaceuticals, Inc., GlaxoSmithKline, MedAvante, Inc., Neuronetics, Inc., Novartis, Schering-Plough, Shire US Inc., Supernus Pharmaceuticals, Takeda, Transcept, Pharmaceuticals, and Wyeth-Ayerst Laboratories
Grant/Research Support: Eli Lilly, GlaxoSmithKline, Sepracor, Inc.
Royalties/Patents/Other Income: American Psychiatric Publishing, Inc., Guilford Publications, Herald House, Oxford University Press, and W.W. Norton & Company
Salaried Positions: Dr. Thase’s wife is employed as the senior medical director for Advogent.
Speaker’s Bureau/CME/Honoraria: AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Wyeth-Ayerst Laboratories
Stock Shareholder: MedAvante, Inc.
Karen D. Wagner MD Ph.D (July 30, 2009)
Advisory Board Fee/Consultant Fee: none
Grant/Research Support: none
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria:
Letters and Sciences, Physician’s Postgraduate Press
Stock Shareholder: none
Sidney Zisook, M.D. (July 8, 2009)
Advisory Board Fee/Consultant Fee: none
Grant/Research Support:
PamLab
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria:
GlaxoSmithKline
Stock Shareholder: none
ASCP Meetings/CME Committee
Jeff Erickson, M.D. (July 9, 2009)
none
Joseph Goldberg, M.D. (September 23, 2009)
Advisory Board Fee/Consultant Fee:
Eli Lilly, Cephalon
Grants/Research Support: none
Royalties/Patents/Other Income: American Psychiatric Press, Inc.
Salaried Positions: none
Speaker’s Bureau/Honoraria: AstraZeneca, Bristol-Myers Squibb, Eli Lilly,
GlaxoSmithKline, Pfizer
Stock Shareholder: Bristol-Myers Squibb, GlaxoSmithKline, SciClone
James W. Jefferson, M.D. (July 8, 2009)
Advisory Board Fee/Consultant Fee:
GlaxoSmithKline
Grants/Research Support: Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Novartis,
Pfizer, Wyeth
Royalties/Patents/Other Income: Various, from time to time, from the pharmaceutical companies listed above
Salaried Positions: Healthcare Technology Systems, Inc. (Principal)
Speaker’s Bureau/Honoraria: Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly,
Wyeth
Stock Shareholder: Bristol-Myers Squibb, GlaxoSmithKline, SciClone
Craig Nelson, M.D. (August 4, 2009)
Advisory Board Fee/Consultant Fee:
Bristol
Myers Squibb, Corcept, Covidien, Eli Lilly, Medtronic, Merck, Orexigen, Otsuka, Sanofi-Aventis, Shire, Sierra Neuropharmaceuticals
Grant/Research Support:
none
Royalties/Patents/Other Income: none
Salaried Positions: none
Speaker’s Bureau/CME/Honoraria:
none
Stock Shareholder: none
James W. Thompson, M.D., M.P.H. (July 1, 2009)
none
ASCP Administrative Staff
James W. Thompson, M.D., M.P.H. (July 1, 2009)
none
Jennifer Russo (July 1, 2009)
none